Abbott Laboratories Stock Buy Hold or Sell Recommendation
| ABT Stock | USD 106.89 0.70 0.65% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Abbott Laboratories is 'Strong Hold'. Macroaxis provides Abbott Laboratories buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ABT positions. The advice algorithm takes into account all of Abbott Laboratories' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Abbott Laboratories' buy or sell advice are summarized below:
Real Value 99.18 | Target Price 110.65 | Hype Value 107.59 | Market Value 106.89 | Naive Value 104.68 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Abbott Laboratories given historical horizon and risk tolerance towards Abbott Laboratories. When Macroaxis issues a 'buy' or 'sell' recommendation for Abbott Laboratories, the advice is generated through an automated system that utilizes algorithms and statistical models.
Abbott |
Execute Abbott Laboratories Buy or Sell Advice
The Abbott recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Abbott Laboratories. Macroaxis does not own or have any residual interests in Abbott Laboratories or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Abbott Laboratories' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Abbott Laboratories Trading Alerts and Improvement Suggestions
| Abbott Laboratories generated a negative expected return over the last 90 days | |
| Over 77.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Its Draft Day Damar Hamlin Helps Build the Abbott HeartMates Team |
Abbott Laboratories Returns Distribution Density
The distribution of Abbott Laboratories' historical returns is an attempt to chart the uncertainty of Abbott Laboratories' future price movements. The chart of the probability distribution of Abbott Laboratories daily returns describes the distribution of returns around its average expected value. We use Abbott Laboratories price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Abbott Laboratories returns is essential to provide solid investment advice for Abbott Laboratories.
| Mean Return | -0.08 | Value At Risk | -2.64 | Potential Upside | 1.78 | Standard Deviation | 1.20 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Abbott Laboratories historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Abbott Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Abbott Laboratories is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Abbott Laboratories backward and forwards among themselves. Abbott Laboratories' institutional investor refers to the entity that pools money to purchase Abbott Laboratories' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Wells Fargo & Co | 2023-12-31 | 16.5 M | Bank Of America Corp | 2023-12-31 | 16.4 M | Bank Of New York Mellon Corp | 2023-12-31 | 15.1 M | Legal & General Group Plc | 2023-12-31 | 14.3 M | State Farm Mutual Automobile Ins Co | 2023-12-31 | 13.6 M | Polen Capital | 2023-12-31 | 13.5 M | Jpmorgan Chase & Co | 2023-12-31 | 13.3 M | Hhg Plc | 2023-12-31 | 13.2 M | Nuveen Asset Management, Llc | 2023-12-31 | 12.4 M | Vanguard Group Inc | 2023-12-31 | 156.4 M | Blackrock Inc | 2023-12-31 | 134.1 M |
Abbott Laboratories Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (593M) | (493M) | (456M) | (1.4B) | (232M) | (243.6M) | |
| Change In Cash | 16M | 3.0B | 3.0B | 83M | (3.0B) | (2.8B) | |
| Free Cash Flow | 4.5B | 5.7B | 8.6B | 7.8B | 5.1B | 4.0B | |
| Depreciation | 3.0B | 3.3B | 3.5B | 3.3B | 3.2B | 1.8B | |
| Other Non Cash Items | 247M | 425M | 55M | 215M | 8.6B | 9.1B | |
| Dividends Paid | 2.3B | 2.6B | 3.2B | 3.3B | 3.6B | 3.7B | |
| Capital Expenditures | 1.6B | 2.2B | 1.9B | 1.8B | 2.2B | 1.2B | |
| Net Income | 3.7B | 4.5B | 7.1B | 6.9B | 5.7B | 3.3B | |
| End Period Cash Flow | 3.9B | 6.8B | 9.8B | 9.9B | 6.9B | 4.0B | |
| Change To Netincome | 582M | 546M | 640M | 685M | 787.8M | 827.1M | |
| Investments | (82M) | (73M) | (96M) | (33M) | (2.9B) | (2.8B) | |
| Change Receivables | (275M) | (924M) | (383M) | (68M) | (61.2M) | (64.3M) | |
| Net Borrowings | (1.6B) | (50M) | (248M) | 47M | 42.3M | 40.2M |
Abbott Laboratories Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Abbott Laboratories or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Abbott Laboratories' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Abbott stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.17 | |
β | Beta against NYSE Composite | 0.90 | |
σ | Overall volatility | 1.16 | |
Ir | Information ratio | -0.15 |
Abbott Laboratories Volatility Alert
Abbott Laboratories exhibits very low volatility with skewness of -0.35 and kurtosis of 0.07. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Abbott Laboratories' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Abbott Laboratories' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Abbott Laboratories Implied Volatility
Abbott Laboratories' implied volatility exposes the market's sentiment of Abbott Laboratories stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Abbott Laboratories' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Abbott Laboratories stock will not fluctuate a lot when Abbott Laboratories' options are near their expiration.
Abbott Laboratories Fundamentals Vs Peers
Comparing Abbott Laboratories' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Abbott Laboratories' direct or indirect competition across all of the common fundamentals between Abbott Laboratories and the related equities. This way, we can detect undervalued stocks with similar characteristics as Abbott Laboratories or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Abbott Laboratories' fundamental indicators could also be used in its relative valuation, which is a method of valuing Abbott Laboratories by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Abbott Laboratories to competition |
| Fundamentals | Abbott Laboratories | Peer Average |
| Return On Equity | 0.15 | -0.31 |
| Return On Asset | 0.0611 | -0.14 |
| Profit Margin | 0.14 % | (1.27) % |
| Operating Margin | 0.14 % | (5.51) % |
| Current Valuation | 194.6 B | 16.62 B |
| Shares Outstanding | 1.74 B | 571.82 M |
| Shares Owned By Insiders | 0.53 % | 10.09 % |
| Shares Owned By Institutions | 77.04 % | 39.21 % |
| Number Of Shares Shorted | 14.48 M | 4.71 M |
| Price To Earning | 24.14 X | 28.72 X |
| Price To Book | 4.90 X | 9.51 X |
| Price To Sales | 4.72 X | 11.42 X |
| Revenue | 40.11 B | 9.43 B |
| Gross Profit | 24.58 B | 27.38 B |
| EBITDA | 10.59 B | 3.9 B |
| Net Income | 5.7 B | 570.98 M |
| Cash And Equivalents | 9.88 B | 2.7 B |
| Cash Per Share | 5.68 X | 5.01 X |
| Total Debt | 15.87 B | 5.32 B |
| Debt To Equity | 0.46 % | 48.70 % |
| Current Ratio | 1.86 X | 2.16 X |
| Book Value Per Share | 22.26 X | 1.93 K |
| Cash Flow From Operations | 7.26 B | 971.22 M |
| Short Ratio | 2.26 X | 4.00 X |
| Earnings Per Share | 3.21 X | 3.12 X |
| Price To Earnings To Growth | 5.99 X | 4.89 X |
| Target Price | 118.91 | |
| Number Of Employees | 114 K | 18.84 K |
| Beta | 0.74 | -0.15 |
| Market Capitalization | 186.69 B | 19.03 B |
| Total Asset | 73.21 B | 29.47 B |
| Retained Earnings | 37.55 B | 9.33 B |
| Working Capital | 8.83 B | 1.48 B |
Abbott Laboratories Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Abbott . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Abbott Laboratories Buy or Sell Advice
When is the right time to buy or sell Abbott Laboratories? Buying financial instruments such as Abbott Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 19.0B | 17.7B | 15.9B | 9.8B | Total Assets | 75.2B | 74.4B | 73.2B | 36.9B |
Use Investing Ideas to Build Portfolios
In addition to having Abbott Laboratories in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Junk Bonds Funds Thematic Idea Now
Junk Bonds Funds
Funds or Etfs that invest most of their assets into speculative (junk) bonds or to other fixed income instruments with interest rates 3 to 4 percentage points above government issues. The Junk Bonds Funds theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Junk Bonds Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Abbott Laboratories Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Abbott Stock analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.07) | Dividend Share 2.12 | Earnings Share 3.21 | Revenue Per Share 23.183 | Quarterly Revenue Growth 0.022 |
The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abbott Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.